StockData
PUREOTCMiscellaneous Chemical ProductsFiscal year ends July 31

PURE BIOSCIENCE, INC.

Financials through Q3 FY2026, quarter ended Apr 30, 2026Last filing: 10-Q on Jun 15, 2026
$0.07−0.01 (-12.10%)

Close on Oct 19, 2026

Market cap
$7.33M
P/E (TTM)
–
Dividend yield
–

About Pure Bioscience

Miscellaneous Chemical Products, SIC 2890

PURE Bioscience, Inc. develops and commercializes antimicrobial products based on patented stabilized ionic silver, specifically Silver Dihydrogen Citrate (SDC). The company produces and sells disinfectant, sanitizing, and cleaning products designed to eliminate pathogens and enhance hygienic control. Key offerings include PURE Hard Surface, an EPA-registered surface disinfectant and sanitizer, and PURE Control, an FDA-approved direct food contact processing aid for produce and poultry. It also provides multi-purpose cleaning concentrates and sells SILVÉRION as a raw material ingredient and preservative for personal care manufacturing. PURE Bioscience serves end-use customers and third-party distributors across industries including food processing, food service and hospitality, healthcare, facility care, transportation, and personal care.

The company operates in North America and holds twelve U.S. patents, while planning to expand patent efforts into Europe, Asia, and Mexico. PURE Bioscience maintains its principal executive offices in El Cajon, California.

Summary of the business section of Pure Bioscience's latest annual report, written by StockData.

Company profile

Company

Legal name
PURE BIOSCIENCE, INC.
Headquarters
El Cajon, CA
Address
771 Jamacha Road #512 92019
Phone
(619) 596-8600
Employees
11, Jul 31, 2025
Industry
Miscellaneous Chemical Products
Incorporated in
Delaware
Fiscal year ends
July 31
Auditor
Weinberg & Company, P.A., Los Angeles, California

Stock & identifiers

Ticker
PURE
Exchange
OTC
Shares outstanding
130M, Jun 15, 2026
Public float
$4.67M, Jan 31, 2025
Filer category
Non-accelerated filer<br>Smaller reporting company
Stock splits
1-for-8 reverse, Aug 15, 2012; 1-for-8 reverse, Jul 31, 2012
SEC CIK
1006028
EIN
33-0530289

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Jeffrey Scott KitchellPresident, Corporate Secretary12,998

Employees

Headcount reported in annual reports

“As of October 29, 2025, we have 11 full-time employees and 1 part-time employee.”

Corporate history

Events identified from SEC filings

DateEventDetails
Nov 20, 2019Auditor changeChange in certifying accountant (8-K Item 4.01)
Dec 10, 2015Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Aug 20, 2013Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Aug 20, 2013DelistingNotice of delisting from exchange (Form 25)
May 17, 2013Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Mar 8, 2013Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Dec 26, 2012Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Oct 5, 2012Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Sep 18, 2012Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Sep 14, 2012Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Aug 16, 2012Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Aug 8, 2012Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Jun 26, 2012Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Mar 28, 2012Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Mar 16, 2012Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Sep 22, 2011Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Mar 17, 2011Name changeName changed from PURE BIOSCIENCE to PURE BIOSCIENCE, INC.
Mar 31, 2008ListingRegistration of securities on an exchange (Form 8-A)
Sep 24, 2007Auditor changeChange in certifying accountant (8-K Item 4.01)
Jun 3, 2005Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Sep 2, 2003Name changeName changed from INNOVATIVE MEDICAL SERVICES to PURE BIOSCIENCE
Nov 15, 2001DeregistrationTermination of SEC registration (Form 15)
Jul 15, 1996ListingRegistration of securities on an exchange (Form 8-A)